Aaron K. Sato

4.3k total citations
41 papers, 2.5k citations indexed

About

Aaron K. Sato is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Aaron K. Sato has authored 41 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Aaron K. Sato's work include Monoclonal and Polyclonal Antibodies Research (23 papers), T-cell and B-cell Immunology (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Aaron K. Sato is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (23 papers), T-cell and B-cell Immunology (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Aaron K. Sato collaborates with scholars based in United States, Australia and Italy. Aaron K. Sato's co-authors include Lawrence J. Stern, Rachel B. Kent, Malini Viswanathan, Clive R. Wood, Robert C. Ladner, Mark de Souza, Laura Santambrogio, Alexander Steiner, Trevor J. Hallam and Gang Yin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Aaron K. Sato

40 papers receiving 2.4k citations

Peers

Aaron K. Sato
Partha S. Chowdhury United States
Jagath R. Junutula United States
Bruno Catimel Australia
John D. Pound United Kingdom
Partha S. Chowdhury United States
Aaron K. Sato
Citations per year, relative to Aaron K. Sato Aaron K. Sato (= 1×) peers Partha S. Chowdhury

Countries citing papers authored by Aaron K. Sato

Since Specialization
Citations

This map shows the geographic impact of Aaron K. Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron K. Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron K. Sato more than expected).

Fields of papers citing papers by Aaron K. Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron K. Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron K. Sato. The network helps show where Aaron K. Sato may publish in the future.

Co-authorship network of co-authors of Aaron K. Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron K. Sato. A scholar is included among the top collaborators of Aaron K. Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron K. Sato. Aaron K. Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Garg, Pankaj, Tom Z. Yuan, Ana González Hernández, et al.. (2024). Discovery of a potent, selective, and tumor-suppressing antibody antagonist of adenosine A2A receptor. PLoS ONE. 19(6). e0301223–e0301223. 1 indexed citations
4.
Peterson, Sean M., Christine A. Juliana, Ana González Hernández, et al.. (2023). Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism. Diabetes. 72(9). 1320–1329. 6 indexed citations
5.
Peterson, Sean M., et al.. (2023). Discovery and design of G protein-coupled receptor targeting antibodies. Expert Opinion on Drug Discovery. 18(4). 417–428. 5 indexed citations
6.
Sato, Aaron K.. (2020). Eliminating Bottlenecks in mAb Drug Discovery. Genetic Engineering & Biotechnology News. 40(7). 48–49. 1 indexed citations
7.
Froude, Jeffrey W., Andrew S. Herbert, Thibaut Pelat, et al.. (2018). Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail. Viruses. 10(6). 286–286. 16 indexed citations
8.
Currier, Nicolas, Shelley E. Ackerman, James R. Kintzing, et al.. (2016). Targeted Drug Delivery with an Integrin-Binding Knottin–Fc–MMAF Conjugate Produced by Cell-Free Protein Synthesis. Molecular Cancer Therapeutics. 15(6). 1291–1300. 30 indexed citations
9.
Yen, Wan-Ching, Marcus Fischer, Fumiko Axelrod, et al.. (2015). Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency. Clinical Cancer Research. 21(9). 2084–2095. 195 indexed citations
10.
Qi, Cai, Jeffrey Hanson, Alexander Steiner, et al.. (2015). A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell‐free protein synthesis systems. Biotechnology Progress. 31(3). 823–831. 76 indexed citations
11.
Kline, Toni, Alexander Steiner, Kalyani Penta, et al.. (2014). Methods to Make Homogenous Antibody Drug Conjugates. Pharmaceutical Research. 32(11). 3480–3493. 54 indexed citations
12.
Hoey, Timothy, Wan-Ching Yen, Fumiko Axelrod, et al.. (2009). DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency. Cell stem cell. 5(2). 168–177. 318 indexed citations
13.
Horst, Edward H. van der, Lawrence Chinn, Min Wang, et al.. (2009). Discovery of Fully Human Anti-MET Monoclonal Antibodies with Antitumor Activity against Colon Cancer Tumor Models In Vivo. Neoplasia. 11(4). 355–IN5. 48 indexed citations
14.
Sato, Aaron K., Malini Viswanathan, Rachel B. Kent, & Clive R. Wood. (2006). Therapeutic peptides: technological advances driving peptides into development. Current Opinion in Biotechnology. 17(6). 638–642. 290 indexed citations
15.
Huang, Lili, et al.. (2005). Discovery of human antibodies against the C5aR target using phage display technology. Journal of Molecular Recognition. 18(4). 327–333. 14 indexed citations
16.
Liu, Guozheng, Charles R. Wescott, Aaron K. Sato, et al.. (2002). Nitriles form mixed-coligand complexes with 99mTc-HYNIC-Peptide. Nuclear Medicine and Biology. 29(1). 107–113. 12 indexed citations
17.
Sato, Aaron K., Daniel J. Sexton, Edward H. Cohen, et al.. (2002). Development of Mammalian Serum Albumin Affinity Purification Media by Peptide Phage Display. Biotechnology Progress. 18(2). 182–192. 73 indexed citations
18.
Sato, Aaron K., Mia Rushe, Aleksey Lomakin, et al.. (2000). Determinants of the Peptide-induced Conformational Change in the Human Class II Major Histocompatibility Complex Protein HLA-DR1. Journal of Biological Chemistry. 275(3). 2165–2173. 72 indexed citations
19.
Sato, Aaron K., et al.. (1999). Empty and Peptide-Loaded Class II Major Histocompatibility Complex Proteins Produced by Expression inEscherichia coliand Foldingin Vitro. Protein Expression and Purification. 15(1). 105–114. 91 indexed citations
20.
Sato, Aaron K., et al.. (1994). Steady-state and time-resolved phosphorescence of wild-type and modified bacteriophage λcI repressors. Journal of Fluorescence. 4(2). 195–201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026